Rapamycin

Recent articles

Micrograph of neuron dendrite segments.

Maternal sleep apnea may contribute to autism-like traits in rats

Pups born to mothers that experience low oxygen during sleep have overactive mTOR signaling, which has been linked to some forms of autism.

By Angie Voyles Askham
18 March 2022 | 5 min read

Autism model mice develop typical social and motor behaviors after drug treatment

The drug suppresses an overactive signaling pathway implicated in tuberous sclerosis complex.

By Laura Dattaro
9 March 2022 | 4 min read

Synaptic overgrowth, hyperconnectivity may define autism subtype

Model mice of the subtype also show hyperactivity in a signaling pathway called mTOR, bolstering the idea that distinct forms of autism have different biological roots and may require different treatment approaches.

By Angie Voyles Askham
18 November 2021 | 4 min read

Molecular overlap links tuberous sclerosis, fragile X

Brain cells from the cerebellums of mice that model tuberous sclerosis show dampened levels of proteins controlled by FMRP, the protein missing in fragile X syndrome.

By Rachel Zamzow
16 August 2021 | 5 min read
Illustration showing the human brain with neurons made out of flower shapes and the cerebellum highlighted in gold and yellow.

Brain’s motor hub plays unsung role in social skills, cognition

Long known as the director of movement, the cerebellum may also coordinate social and cognitive abilities, including those central to autism.

By Sarah DeWeerdt
9 March 2020 | 7 min read

Mouse study reveals overlooked target for autism therapies

Blocking one form of an enzyme implicated in autism eases unusual behaviors and seizures in mice missing a top autism gene.

By Nicholette Zeliadt
20 November 2019 | 4 min read
row of babies playing with toys that look like genome sequence

Studies of tuberous sclerosis may shed light on biology of autism

Tuberous sclerosis provides a unique opportunity to understand autism because about half of people with that single-gene condition also have autism.

By Mustafa Sahin
24 September 2019 | 5 min read
Two scientists standing in a lab.

Family ties: Sabatini brothers crack codes that may underlie autism

David and Bernardo Sabatini, brothers born just a year and a half year apart, invent their way to answering big questions about autism.

By Hannah Furfaro
30 August 2018 | 9 min read
group of rats on wood chips

Drug in trials for one autism-linked condition may worsen another

The drug rapamycin, which is in clinical trials as a treatment for tuberous sclerosis, may exacerbate features of fragile X syndrome, another condition related to autism.

By Hannah Furfaro
26 January 2018 | 4 min read
Mice missing the tuberous sclerosis gene in astrocytes have frequent seizures.

Cancer drug wards off seizures in mouse model of tuberous sclerosis

A drug called rapamycin prevents seizures in a mouse model of the autism-related condition tuberous sclerosis complex.

By Hannah Furfaro
13 November 2017 | 3 min read

Explore more from The Transmitter

Two hands hold a paper airplane.

How will neuroscience training need to change in the future?

Training in computational neuroscience, data science and statistics will need to expand, say many of the scientists we surveyed. But that must be balanced with a more traditional grounding in the scientific method and critical thinking. Researchers noted that funding concerns will also affect training, especially for people from underrepresented groups.

By The Transmitter
15 November 2025 | 11 min read
Composite of headshots of neuroscientists who passed away in the past several years.

The leaders we have lost

Learn more about the lives and legacies of the neuroscientists who passed away between 2023 and 2025.

By The Transmitter
15 November 2025 | 4 min read
Stack of papers.

What are the most-cited neuroscience papers from the past 30 years?

Highly cited papers reflect the surge in artificial-intelligence research in the field and other technical advances, plus prizewinning work on analgesics, the fusiform face area and ion channels.

By The Transmitter
15 November 2025 | 11 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.